Paul R. Fortin

Paul R. Fortin

Université Laval

H-index: 93

North America-Canada

About Paul R. Fortin

Paul R. Fortin, With an exceptional h-index of 93 and a recent h-index of 55 (since 2020), a distinguished researcher at Université Laval, specializes in the field of Systemic Autoimmune Rheumatic Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry

SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice

Two-Year Survivorship and Patient-Reported Outcomes of a Prospectively Enrolled Cohort of INFINITY Total Ankle Arthroplasties

Remission and Low Disease Activity are Associated with Lower Health Care Costs: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for …

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases

Paul R. Fortin Information

University

Position

Professor of Medicine

Citations(all)

41562

Citations(since 2020)

16095

Cited By

31607

hIndex(all)

93

hIndex(since 2020)

55

i10Index(all)

305

i10Index(since 2020)

234

Email

University Profile Page

Google Scholar

Paul R. Fortin Skills & Research Interests

Systemic Autoimmune Rheumatic Diseases

Top articles of Paul R. Fortin

Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry

Journal of the American Academy of Dermatology

2024/3/1

SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice

Communications Biology

2024/2/16

Two-Year Survivorship and Patient-Reported Outcomes of a Prospectively Enrolled Cohort of INFINITY Total Ankle Arthroplasties

Foot & Ankle International

2024/2

Remission and Low Disease Activity are Associated with Lower Health Care Costs: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Annals of the Rheumatic Diseases

2024/4/30

Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

Lupus science & medicine

2024/4/1

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for …

Seminars in Arthritis and Rheumatism

2024/4/1

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Rheumatology

2024/3/1

Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases

The Journal of Rheumatology

2023/7/1

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and …

Arthritis & rheumatology (Hoboken, NJ)

2023/3/2

Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study

Arthritis Care & Research

2023/2

“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis

Pediatric Rheumatology

2023/7/26

Associations among antiphospholipid antibody types, isotypes, and titers: an antiphospholipid syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Laboratory Investigation

2023/6/1

SARS-CoV-2 evolution in the absence of selective immune pressures, results in antibody resistance, interferon suppression and phenotypic differences by lineage

2023/1/17

Natural evolution of SARS-CoV-2 variants in K18-ACE2 mice gives rise to more virulent virus and variant alleles associated with treatment resistance

bioRxiv

2023/1/17

Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort

Arthritis & Rheumatology

2023/12

Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A …

Arthritis Care & Research

2023/10

COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna …

RMD open

2023/11/1

Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience

Annals of the rheumatic diseases

2023/11/1

See List of Professors in Paul R. Fortin University(Université Laval)

Co-Authors

academic-engine